A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis.
Phase of Trial: Phase I
Latest Information Update: 06 May 2014
At a glance
- Drugs Abrilumab (Primary) ; Abrilumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- 06 May 2014 Results published in the British Journal of Clinical Pharmacology.
- 24 Jul 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 May 2013 Interim results of a combined analysis of this trial and trial 700194409 presented at the Digestive Disease Week 2013.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History